Literature DB >> 12563561

Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2.

Marcella Zollino1, Rosetta Lecce, Rita Fischetto, Marina Murdolo, Francesca Faravelli, Angelo Selicorni, Cinzia Buttè, Luigi Memo, Giuseppe Capovilla, Giovanni Neri.   

Abstract

In an attempt to define the distinctive Wolf-Hirschhorn syndrome (WHS) phenotype, and to map its specific clinical manifestations, a total of eight patients carrying a 4p16.3 microdeletion were analyzed for their clinical phenotype and their respective genotypes. The extent of each individual deletion was established by fluorescence in situ hybridization, with a cosmid contig spanning the genomic region from MSX1 (distal half of 4p16.1) to the subtelomeric locus D4S3359. The deletions were 1.9-3.5 Mb, and all were terminal. All the patients presented with a mild phenotype, in which major malformations were usually absent. It is worth noting that head circumference was normal for height in two patients (those with the smallest deletions [1.9 and 2.2 Mb]). The currently accepted WHS critical region (WHSCR) was fully preserved in the patient with the 1.9-Mb deletion, in spite of a typical WHS phenotype. The deletion in this patient spanned the chromosome region from D4S3327 (190 b4 cosmid clone included) to the telomere. From a clinical point of view, the distinctive WHS phenotype is defined by the presence of typical facial appearance, mental retardation, growth delay, congenital hypotonia, and seizures. These signs represent the minimal diagnostic criteria for WHS. This basic phenotype maps distal to the currently accepted WHSCR. Here, we propose a new critical region for WHS, and we refer to this region as "WHSCR-2." It falls within a 300-600-kb interval in 4p16.3, between the loci D4S3327 and D4S98-D4S168. Among the candidate genes already described for WHS, LETM1 (leucine zipper/EF-hand-containing transmembrane) is likely to be pathogenetically involved in seizures. On the basis of genotype-phenotype correlation analysis, dividing the WHS phenotype into two distinct clinical entities, a "classical" and a "mild" form, is recommended for the purpose of proper genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563561      PMCID: PMC1180235          DOI: 10.1086/367925

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones.

Authors:  P Lichter; C J Tang; K Call; G Hermanson; G A Evans; D Housman; D C Ward
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

2.  Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome.

Authors:  M Zollino; C Di Stefano; G Zampino; P Mastroiacovo; T J Wright; G Sorge; A Selicorni; R Tenconi; A Zappalà; A Battaglia; M Di Rocco; G Palka; R Pallotta; M R Altherr; G Neri
Journal:  Am J Med Genet       Date:  2000-09-18

3.  A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene.

Authors:  S Baxendale; M E MacDonald; R Mott; F Francis; C Lin; S F Kirby; M James; G Zehetner; H Hummerich; J Valdes
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

4.  First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype-phenotype correlation.

Authors:  A Rauch; S Schellmoser; C Kraus; H G Dörr; U Trautmann; M R Altherr; R A Pfeiffer; A Reis
Journal:  Am J Med Genet       Date:  2001-04-01

5.  Comparative analysis of a novel gene from the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome critical region.

Authors:  T J Wright; J L Costa; C Naranjo; P Francis-West; M R Altherr
Journal:  Genomics       Date:  1999-07-15       Impact factor: 5.736

6.  LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients.

Authors:  S Endele; M Fuhry; S J Pak; B U Zabel; A Winterpacht
Journal:  Genomics       Date:  1999-09-01       Impact factor: 5.736

7.  FISH detection of Wolf-Hirschhorn syndrome: exclusion of D4F26 as critical site.

Authors:  V P Johnson; M R Altherr; J M Blake; L D Keppen
Journal:  Am J Med Genet       Date:  1994-08-01

8.  Molecular definition of the smallest region of deletion overlap in the Wolf-Hirschhorn syndrome.

Authors:  K Y Gandelman; L Gibson; M S Meyn; T L Yang-Feng
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

9.  Preliminary phenotypic map of chromosome 4p16 based on 4p deletions.

Authors:  L L Estabrooks; K W Rao; D A Driscoll; B F Crandall; J C Dean; E Ikonen; B Korf; A S Aylsworth
Journal:  Am J Med Genet       Date:  1995-07-17

10.  Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)].

Authors:  M G Wilson; J W Towner; G S Coffin; A J Ebbin; E Siris; P Brager
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

View more
  50 in total

1.  Clinical utility gene card for: Wolf-Hirschhorn (4p-) syndrome.

Authors:  Agatino Battaglia; Sarah South; John C Carey
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

2.  C4ORF48, a gene from the Wolf-Hirschhorn syndrome critical region, encodes a putative neuropeptide and is expressed during neocortex and cerebellar development.

Authors:  Sabine Endele; Claudia Nelkenbrecher; Annegret Bördlein; Stefanie Schlickum; Andreas Winterpacht
Journal:  Neurogenetics       Date:  2011-02-02       Impact factor: 2.660

Review 3.  From microscopes to microarrays: dissecting recurrent chromosomal rearrangements.

Authors:  Beverly S Emanuel; Sulagna C Saitta
Journal:  Nat Rev Genet       Date:  2007-11       Impact factor: 53.242

4.  Diverse mutational mechanisms cause pathogenic subtelomeric rearrangements.

Authors:  Yue Luo; Karen E Hermetz; Jodi M Jackson; Jennifer G Mulle; Anne Dodd; Karen D Tsuchiya; Blake C Ballif; Lisa G Shaffer; Jannine D Cody; David H Ledbetter; Christa L Martin; M Katharine Rudd
Journal:  Hum Mol Genet       Date:  2011-07-04       Impact factor: 6.150

5.  Dissecting the Wolf-Hirschhorn syndrome phenotype: WHSC1 is a neurodevelopmental gene contributing to growth delay, intellectual disability, and to the facial dysmorphism.

Authors:  Marcella Zollino; Paolo Niccolo' Doronzio
Journal:  J Hum Genet       Date:  2018-06-08       Impact factor: 3.172

Review 6.  Ocular coloboma: a reassessment in the age of molecular neuroscience.

Authors:  C Y Gregory-Evans; M J Williams; S Halford; K Gregory-Evans
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

7.  Transgenic rescue of the mouse t complex haplolethal locus Thl1.

Authors:  Gareth R Howell; Robert J Munroe; John C Schimenti
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

8.  Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome.

Authors:  Erica F Andersen; John C Carey; Dawn L Earl; Deyanira Corzo; Michael Suttie; Peter Hammond; Sarah T South
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

9.  De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features.

Authors:  Ekaterina R Lozier; Fedor A Konovalov; Ilya V Kanivets; Denis V Pyankov; Philip A Koshkin; Larisa S Baleva; Alla E Sipyagina; Elena N Yakusheva; Anastasiya E Kuchina; Sergey A Korostelev
Journal:  J Hum Genet       Date:  2018-05-14       Impact factor: 3.172

10.  Deletion of a 760 kb region at 4p16 determines the prenatal and postnatal growth retardation characteristic of Wolf-Hirschhorn syndrome.

Authors:  Daniela Concolino; Elena Rossi; Pietro Strisciuglio; Maria Antonietta Iembo; Roberto Giorda; Roberto Ciccone; Romano Tenconi; Orsetta Zuffardi
Journal:  J Med Genet       Date:  2007-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.